Investor Relations
An Opportunity at the Intersection of Predictive AI and Connected Healthcare.
Investment thesis
Building on an existing platform.
CuraVeyra is building upon an existing technology platform to address remote monitoring, clinical workflow fragmentation and potential early recognition of patient deterioration.
Market opportunity
Structural shifts in where care happens.
U.S. remote patient monitoring
Chronic disease management
Post-discharge programs
Aging population
Hospital-at-home
AI-assisted care coordination
Market sizing figures will be published only with dated, cited sources.
Business model
Potential B2B recurring revenue.
Under evaluation
- Per monitored patient
- Enterprise platform licensing
- Clinical program implementation
- Device management
- Workflow integrations
Pricing and commercial structures are proposed and will be refined through pilots and partner discussions.
Milestones
Roadmap
2026
- Technical testing
- Device and data integration
- Initial internal validation
- U.S. regulatory planning
2027
- Planned hospital and care-facility pilot programs, subject to agreements, approvals and regulatory requirements
- Clinical evidence collection
- Expanded partner development
- Assessment of U.S. go-to-market readiness
Request Investor Information
Qualified investors can request our investor materials. Confidential terms are shared only privately.